Candriam S.C.A. grew its stake in shares of Oracle Corporation (NYSE:ORCL – Free Report) by 31.2% during the second quarter, HoldingsChannel.com reports. The fund owned 155,363 shares of the enterprise software provider’s stock after buying an additional 36,975 shares during the quarter. Candriam S.C.A.’s holdings in Oracle were worth $33,968,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also recently made changes to their positions in the stock. Nuveen LLC purchased a new stake in Oracle during the 1st quarter valued at $732,692,000. Vanguard Group Inc. increased its position in Oracle by 2.2% during the first quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider’s stock valued at $22,498,982,000 after acquiring an additional 3,513,464 shares during the last quarter. Kingstone Capital Partners Texas LLC bought a new position in Oracle in the second quarter valued at about $731,512,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Oracle by 79.2% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,638,951 shares of the enterprise software provider’s stock worth $648,572,000 after purchasing an additional 2,049,687 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its stake in shares of Oracle by 840.7% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,119,473 shares of the enterprise software provider’s stock valued at $463,380,000 after purchasing an additional 1,894,157 shares during the period. 42.44% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on the stock. BMO Capital Markets set a $355.00 price objective on shares of Oracle and gave the stock an “outperform” rating in a research note on Monday, October 13th. The Goldman Sachs Group reiterated a “neutral” rating and issued a $320.00 price target on shares of Oracle in a research report on Monday, October 20th. Evercore ISI lifted their price target on shares of Oracle from $350.00 to $385.00 and gave the stock an “outperform” rating in a research note on Friday, October 17th. Melius Research upped their price objective on Oracle from $270.00 to $370.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Finally, Rothschild & Co Redburn started coverage on Oracle in a research report on Thursday, September 25th. They set a “sell” rating and a $175.00 target price on the stock. Three research analysts have rated the stock with a Strong Buy rating, twenty-seven have issued a Buy rating, ten have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, Oracle currently has an average rating of “Moderate Buy” and an average target price of $323.69.
Oracle Trading Down 4.0%
Shares of Oracle stock opened at $226.66 on Thursday. Oracle Corporation has a fifty-two week low of $118.86 and a fifty-two week high of $345.72. The company has a debt-to-equity ratio of 3.33, a quick ratio of 0.62 and a current ratio of 0.62. The company has a market capitalization of $646.16 billion, a P/E ratio of 52.47, a P/E/G ratio of 2.96 and a beta of 1.51. The company has a fifty day moving average of $279.89 and a 200 day moving average of $232.67.
Oracle (NYSE:ORCL – Get Free Report) last announced its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing the consensus estimate of $1.48 by ($0.01). Oracle had a net margin of 21.08% and a return on equity of 72.93%. The business had revenue of $14.93 billion during the quarter, compared to analysts’ expectations of $15.04 billion. During the same quarter in the previous year, the firm earned $1.39 earnings per share. Oracle’s revenue was up 12.2% on a year-over-year basis. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, sell-side analysts anticipate that Oracle Corporation will post 5 earnings per share for the current fiscal year.
Oracle Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.9%. The ex-dividend date was Thursday, October 9th. Oracle’s dividend payout ratio is presently 46.30%.
Insider Buying and Selling at Oracle
In related news, Director Jeffrey Berg sold 49,365 shares of the firm’s stock in a transaction on Tuesday, October 28th. The shares were sold at an average price of $283.02, for a total transaction of $13,971,282.30. Following the completion of the transaction, the director directly owned 151,999 shares of the company’s stock, valued at approximately $43,018,756.98. This trade represents a 24.52% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Maria Smith sold 5,000 shares of the business’s stock in a transaction on Thursday, October 23rd. The stock was sold at an average price of $280.62, for a total transaction of $1,403,100.00. Following the completion of the sale, the executive vice president owned 47,083 shares in the company, valued at approximately $13,212,431.46. The trade was a 9.60% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 204,254 shares of company stock worth $60,227,807. Insiders own 40.90% of the company’s stock.
About Oracle
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Stories
- Five stocks we like better than Oracle
- What to Know About Investing in Penny Stocks
- Rare Earth Stocks: The Truce That Isn’t a Truce
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- What is the Dogs of the Dow Strategy? Overview and Examples
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
